268 related articles for article (PubMed ID: 24588402)
1. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
[TBL] [Abstract][Full Text] [Related]
2. Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model.
Gladding CM; Sepers MD; Xu J; Zhang LY; Milnerwood AJ; Lombroso PJ; Raymond LA
Hum Mol Genet; 2012 Sep; 21(17):3739-52. PubMed ID: 22523092
[TBL] [Abstract][Full Text] [Related]
3. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
[TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice.
Dau A; Gladding CM; Sepers MD; Raymond LA
Neurobiol Dis; 2014 Feb; 62():533-42. PubMed ID: 24269729
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA
J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965
[TBL] [Abstract][Full Text] [Related]
6. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
7. Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.
Saavedra A; Giralt A; Rué L; Xifró X; Xu J; Ortega Z; Lucas JJ; Lombroso PJ; Alberch J; Pérez-Navarro E
J Neurosci; 2011 Jun; 31(22):8150-62. PubMed ID: 21632937
[TBL] [Abstract][Full Text] [Related]
8. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
9. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR-STEP
He RB; Li L; Liu LZ; Ma YJ; Fan SJ; Liu LR; Li WB; Xian XH
J Neurochem; 2023 Jul; 166(2):215-232. PubMed ID: 37284938
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
Fernandes HB; Baimbridge KG; Church J; Hayden MR; Raymond LA
J Neurosci; 2007 Dec; 27(50):13614-23. PubMed ID: 18077673
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
13. Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease.
Chambon J; Komal P; Lewitus GM; Kemp GM; Valade S; Adaïdi H; Al Bistami N; Stellwagen D
J Neurosci; 2023 Jan; 43(4):672-680. PubMed ID: 36517241
[TBL] [Abstract][Full Text] [Related]
14. Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway.
Xu J; Kurup P; Foscue E; Lombroso PJ
J Neurochem; 2015 Aug; 134(4):629-41. PubMed ID: 25951993
[TBL] [Abstract][Full Text] [Related]
15. p35 hemizygosity activates Akt but does not improve motor function in the YAC128 mouse model of Huntington's disease.
Park KHJ; Franciosi S; Parrant K; Lu G; Leavitt BR
Neuroscience; 2017 Jun; 352():79-87. PubMed ID: 28391013
[TBL] [Abstract][Full Text] [Related]
16. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
Fan MM; Fernandes HB; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2007 Apr; 27(14):3768-79. PubMed ID: 17409241
[TBL] [Abstract][Full Text] [Related]
17. Restored Fyn Levels in Huntington's Disease Contributes to Enhanced Synaptic GluN2B-Composed NMDA Receptors and CREB Activity.
Fão L; Coelho P; Rodrigues RJ; Rego AC
Cells; 2022 Sep; 11(19):. PubMed ID: 36231023
[No Abstract] [Full Text] [Related]
18. Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease.
Pellman JJ; Hamilton J; Brustovetsky T; Brustovetsky N
J Neurochem; 2015 Aug; 134(4):652-67. PubMed ID: 25963273
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
Tang TS; Chen X; Liu J; Bezprozvanny I
J Neurosci; 2007 Jul; 27(30):7899-910. PubMed ID: 17652581
[TBL] [Abstract][Full Text] [Related]
20. STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.
Kurup PK; Xu J; Videira RA; Ononenyi C; Baltazar G; Lombroso PJ; Nairn AC
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1202-7. PubMed ID: 25583483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
